EUVIMEDEUVIMED entdecken
Crossref

Thoracoscopic Left Atrial Appendage Exclusion for Atrial Fibrillation Patients Intolerant to Anticoagulation

Omar M Sharaf, Matheus P Falasa, Todd E Jones, Anna Y Khanna, Kun Xiang, Philip George, Vilma Torres, William M Miles, Thomas M Beaver

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery · 2023

DOI: 10.1177/15569845231163857 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery, 2023. Verfasst von Omar M Sharaf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Cardiovascular Surgery, University of Florida Health, Gainesville, FL, USA. Hauptthemen laut MEDLINE: Atrial Fibrillation, Atrial Appendage, Cardiac Surgical Procedures, Stroke. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Outcomes associated with isolated epicardial left atrial appendage (LAA) exclusion in atrial fibrillation (AF) patients with a contraindication or intolerance to anticoagulation are not clearly defined, especially in patients with prior stroke. This study evaluated the perioperative safety, medication use, and stroke outcomes for isolated thoracoscopic LAA exclusion for stroke prevention.

Methods

A single-center retrospective study was performed of adults undergoing isolated thoracoscopic LAA exclusion with an epicardial exclusion device without a concomitant surgical procedure. Descriptive statistics were performed.

Results

Twenty-five patients met the inclusion criteria. The cohort was 68% male ( n = 17) with a mean age of 76.4 ± 6.5 years, a mean preoperative CHA 2 DS 2 -VASc score of 4.2 ± 1.4, and a mean preoperative HAS-BLED score of 2.68 ± 1.03. Seventeen patients (68%) had nonparoxysmal AF. There were 11 patients with intolerance of anticoagulation due to intracranial hemorrhage (44%), 6 due to gastrointestinal bleeding (24%), and 4 due to genitourinary bleeding (16%). All procedures were performed thoracoscopically with 100% technical success—the mean LAA stump length was 5.5 ± 2.3 mm on intraoperative transesophageal echocardiography. The median hospital length of stay was 2 (interquartile range [IQR] 1, 6.5) days. The median follow-up time was 430 (IQR 125, 972) days. During follow-up, 1 patient with cerebral angiopathy had temporary neurologic deficits at an outside institution, with brain imaging showing no evidence of ischemic injury. There were no other thromboembolic events over the 38.8 postoperative patient-years examined. All patients were off anticoagulation at last follow-up.

Conclusions

This study shows the perioperative safety, technical success, freedom from anticoagulation, and stroke outcomes of isolated thoracoscopic LAA exclusion in patients with AF at high risk for thromboembolic disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationAtrial AppendageCardiac Surgical ProceduresStrokeHumansMaleAgedAged, 80 and overFemaleRetrospective StudiesTreatment OutcomeEchocardiography, TransesophagealAnticoagulants

Stichwörter der Autor:innen

anticoagulationatrial fibrillationepicardial left atrial appendage closureleft atrial appendagestroke

Substanzen

Anticoagulants

Autor:innen und Institutionen

  • Department of Surgery, Division of Cardiovascular Surgery, University of Florida Health, Gainesville, FL, USA.
  • Department of Anesthesiology, Division of Cardiothoracic Anesthesia, University of Florida Health, Gainesville, FL, USA.
  • Department of Neurology, University of Florida Health, Gainesville, FL, USA.
  • Department of Medicine, Division of Cardiovascular Medicine, University of Florida Health, Gainesville, FL, USA.

Zitieren

APA

Sharaf, O. M., Falasa, M. P., Jones, T. E., Khanna, A. Y., Xiang, K., George, P., Torres, V., Miles, W. M., & Beaver, T. M. (2023). Thoracoscopic Left Atrial Appendage Exclusion for Atrial Fibrillation Patients Intolerant to Anticoagulation. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. https://doi.org/10.1177/15569845231163857

Vancouver

Sharaf OM, Falasa MP, Jones TE, Khanna AY, Xiang K, George P, et al. Thoracoscopic Left Atrial Appendage Exclusion for Atrial Fibrillation Patients Intolerant to Anticoagulation. Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery. 2023. doi:10.1177/15569845231163857

BibTeX
@article{Sharaf2023,
  author = {Sharaf, Omar M and Falasa, Matheus P and Jones, Todd E and Khanna, Anna Y and Xiang, Kun and George, Philip and Torres, Vilma and Miles, William M and Beaver, Thomas M},
  title = {Thoracoscopic Left Atrial Appendage Exclusion for Atrial Fibrillation Patients Intolerant to Anticoagulation},
  journal = {Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery},
  year = {2023},
  doi = {10.1177/15569845231163857}
}
Kostenlos starten →